Bruce Jackson
Stock Analyst at Benchmark
(0.10)
# 4,234
Out of 4,880 analysts
123
Total ratings
6.45%
Success rate
-47.14%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.68 | +307.41% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $2.29 | +512.69% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.46 | +555.88% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $4.00 | +725.00% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.86 | +704.20% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $58.10 | +37.69% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $7.43 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $54.60 | +19.06% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.78 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $30 | $4.90 | +512.24% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.67 | +87.41% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.21 | +147.93% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.17 | +130.41% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.69 | +4,242.79% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $3.55 | +1,590.14% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.37 | +4,530.89% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.04 | +2,207.69% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $1.82 | -45.05% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.71 | +605.92% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.17 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.00 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.85 | +20,679.22% | 1 | Aug 8, 2022 |
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.68
Upside: +307.41%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $2.29
Upside: +512.69%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.46
Upside: +555.88%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $4.00
Upside: +725.00%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.86
Upside: +704.20%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $58.10
Upside: +37.69%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.43
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $54.60
Upside: +19.06%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.78
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.90
Upside: +512.24%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.67
Upside: +87.41%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.21
Upside: +147.93%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.17
Upside: +130.41%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.69
Upside: +4,242.79%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $3.55
Upside: +1,590.14%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.37
Upside: +4,530.89%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.04
Upside: +2,207.69%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $1.82
Upside: -45.05%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.71
Upside: +605.92%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.17
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $17.00
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.85
Upside: +20,679.22%